Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Adenosine Triphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 known ✓ | P47900 | 9/20 | 0.78 |
| ▸ | P2RY2 known ✓ | P41231 | 3/20 | 0.78 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 0.78 |
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.78 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.78 |
| ▸ | P2RY11 | Q96G91 | 3/20 | 0.78 |
| ▸ | SRC | P12931 | 2/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.78 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.78 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.78 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.78 |
| ▸ | LDHA | P00338 | 1/20 | 0.78 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.78 |
| ▸ | FBP1 | P09467 | 1/20 | 0.78 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.78 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.78 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.78 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.78 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.78 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Triphosphate SCHEMBL29352529 | 1.00 | P2RY1 (0.78) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL27881873 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL3332142 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL30786396 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL29760430 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL3498805 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL4594623 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL29371640 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL26184967 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL27531093 | 0.98 | P2RY1 (0.75) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1629 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117717494-B | Composition with double effects of whitening and smoothing skin, cosmetic and preparation method | McGill Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-222988763-U | Adenosine disodium triphosphate raw material storage device | 广西明健药业有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120148753-A | Exercise rehabilitation system and method for patient with angina pectoris after PCI operation | 中国人民解放军总医院第八医学中心 | 2025-06-13 | — | — | CN | claimed |
| CN-120078664-A | Hair-fixing and hair-losing-preventing composition and application thereof, and hair-fixing and hair-preventing be temporarily released from one's regular work product | 上海中翊日化有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120053314-A | Hair-fixing and hair-losing-preventing composition and application thereof, and hair-fixing and hair-preventing be temporarily released from one's regular work product | 上海中翊日化有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119924295-A | Cell preservation solution and application thereof | 深圳华大基因细胞科技有限责任公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119530193-A | Adenosine kinase mutant with high thermal stability and application thereof | 杭州美亚药业股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119432959-A | Process for preparing NAD+ by enzymatic catalysis | 安徽瑞邦生物科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118303531-B | Additive composition and application thereof | 中国长江三峡集团有限公司中华鲟研究所 | 2025-02-11 | — | — | CN | claimed |
| CN-222241798-U | Cleaning device for adenosine disodium triphosphate magnesium chloride packaging bottle for injection | 山西振东泰盛制药有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-5702691-A | Flavanonol derivatives and hair-nourishing, hair growing compositions containing the derivatives | KAO CORPORATION (JP) | 1997-12-30 | — | — | US | claimed |
| US-5658578-A | DISODIUM ADENOSINE TRIPHOSPHATE, TRANSEXAMIC ACID, GINSENG EXTRACT | SHISEIDO COMPANY, LTD. (JP) | 1997-08-19 | — | — | US | claimed |
| EP-0685229-A1 | Skin cosmetic composition | SHISEIDO COMPANY LIMITED (JP) | 1995-12-06 | — | — | EP | claimed |
| US-5420116-A | Pharmaceutical compositions for the treatment of disorders of the respiratory tract | SYNTHELABO (FR) | 1995-05-30 | — | — | US | claimed |
| EP-0344795-B1 | Stabilized pharmaceutical composition and method of producing same | SENJU PHARMA CO (JP) | 1994-02-16 | — | — | EP | claimed |
| EP-0348688-B1 | SOLID PHARMACEUTICAL PREPARATION AND METHOD OF PRODUCING SAME | Senju Pharmaceutical Co., Ltd. (JP) | 1992-04-15 | — | — | EP | claimed |
| US-5055304-A | Containing disodium adenosine triphosphate and low melting fat or oil-like component; cardiovascular disorders, asthenopia | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1991-10-08 | — | — | US | claimed |
| US-5017564-A | Vitamin B1 deravitive and disodium ATP | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1991-05-21 | — | — | US | claimed |
| EP-0348688-A1 | Solid pharmaceutical preparation and method of producing same | Senju Pharmaceutical Co., Ltd. (JP) | 1990-01-03 | — | — | EP | claimed |
| EP-0344795-A1 | Stabilized pharmaceutical composition and method of producing same | Senju Pharmaceutical Co., Ltd. (JP) | 1989-12-06 | — | — | EP | claimed |